CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C05204 | BRD-K08881846 | BRD-K08881846 | -- | -- | -- | Details |
| C05205 | BRD-K08884733 | BRD-K08884733 | -- | -- | -- | Details |
| C05206 | BRD-K08887444 | BRD-K08887444 | -- | -- | -- | Details |
| C05207 | BRD-K08890269 | CO-102862 | -- | -- | -- | Details |
| C05208 | BRD-K08891029 | BRD-K08891029 | -- | -- | -- | Details |
| C05209 | BRD-K08899466 | BRD-K08899466 | -- | -- | -- | Details |
| C05210 | BRD-K08903301 | BRD-K08903301 | -- | -- | -- | Details |
| C05211 | BRD-K08911251 | BRD-K08911251 | -- | -- | -- | Details |
| C05212 | BRD-K08920503 | BRD-K08920503 | -- | -- | -- | Details |
| C05213 | BRD-K08922114 | BRD-K08922114 | -- | -- | -- | Details |
| C05214 | BRD-K08924299 | palonosetron | HTR3A | Serotonin receptor antagonist | -- | Details |
| C05215 | BRD-K08926145 | BRD-K08926145 | -- | -- | -- | Details |
| C05216 | BRD-K08927194 | BRD-K08927194 | -- | -- | -- | Details |
| C05217 | BRD-K08929846 | BRD-K08929846 | -- | -- | -- | Details |
| C05218 | BRD-K08936794 | BRD-K08936794 | -- | -- | -- | Details |
| C05219 | BRD-K08938154 | BRD-K08938154 | -- | -- | -- | Details |
| C05220 | BRD-K08939002 | BRD-K08939002 | -- | -- | -- | Details |
| C05221 | BRD-K08939947 | BRD-K08939947 | -- | -- | -- | Details |
| C05222 | BRD-K08940439 | BRD-K08940439 | -- | -- | -- | Details |
| C05223 | BRD-K08941280 | BRD-K08941280 | -- | -- | -- | Details |
| C05224 | BRD-K08942755 | BRD-K08942755 | -- | -- | -- | Details |
| C05225 | BRD-K08959882 | BRD-K08959882 | -- | -- | -- | Details |
| C05226 | BRD-K08963966 | BRD-K08963966 | -- | -- | -- | Details |
| C05227 | BRD-K08966355 | BRD-K08966355 | -- | -- | -- | Details |
| C05228 | BRD-K08970510 | BRD-K08970510 | -- | -- | -- | Details |
| C05229 | BRD-K08970894 | DMSO | -- | -- | -- | Details |
| C05230 | BRD-K08971733 | BRD-K08971733 | -- | -- | -- | Details |
| C05231 | BRD-K08972808 | BRD-K08972808 | -- | -- | -- | Details |
| C05232 | BRD-K08973992 | linoleic-acid | -- | -- | -- | Details |
| C05233 | BRD-K08974502 | BRD-K08974502 | -- | -- | -- | Details |
| C05234 | BRD-K08976401 | azelaic-acid | TYR | Tyrosinase inhibitor | -- | Details |
| C05235 | BRD-K08982277 | BRD-K08982277 | -- | -- | -- | Details |
| C05236 | BRD-K08982647 | BRD-K08982647 | -- | -- | -- | Details |
| C05237 | BRD-K08993600 | BRD-K08993600 | -- | -- | -- | Details |
| C05238 | BRD-K08995282 | BRD-K08995282 | -- | -- | -- | Details |
| C05239 | BRD-K08995626 | BRD-K08995626 | -- | -- | -- | Details |
| C05240 | BRD-K08995965 | BRD-K08995965 | -- | -- | -- | Details |
| C05241 | BRD-K08996393 | BRD-K08996393 | -- | -- | -- | Details |
| C05242 | BRD-K08996725 | zolantidine | -- | -- | -- | Details |
| C05243 | BRD-K08996802 | BRD-K08996802 | -- | -- | -- | Details |
| C05244 | BRD-K08998509 | fananserin | DRD4; HTR2A | Dopamine receptor antagonist; Serotonin receptor antagonist | -- | Details |
| C05245 | BRD-K08999871 | pipemidic-acid | -- | -- | -- | Details |
| C05246 | BRD-K09002810 | BRD-K09002810 | -- | -- | -- | Details |
| C05247 | BRD-K09008126 | BRD-K09008126 | -- | -- | -- | Details |
| C05248 | BRD-K09014535 | BRD-K09014535 | -- | -- | -- | Details |
| C05249 | BRD-K09017160 | BRD-K09017160 | -- | -- | -- | Details |
| C05250 | BRD-K09019812 | BRD-K09019812 | -- | -- | -- | Details |
| C05251 | BRD-K09023525 | BRD-K09023525 | -- | -- | -- | Details |
| C05252 | BRD-K09029418 | BRD-K09029418 | -- | -- | -- | Details |
| C05253 | BRD-K09031632 | BRD-K09031632 | -- | -- | -- | Details |
| C05254 | BRD-K09032125 | BRD-K09032125 | -- | -- | -- | Details |
| C05255 | BRD-K09033315 | BRD-K09033315 | -- | -- | -- | Details |
| C05256 | BRD-K09050080 | BRD-K09050080 | -- | -- | -- | Details |
| C05257 | BRD-K09051149 | BRD-K09051149 | -- | -- | -- | Details |
| C05258 | BRD-K09054764 | BRD-K09054764 | -- | -- | -- | Details |
| C05259 | BRD-K09057839 | BRD-K09057839 | -- | -- | -- | Details |
| C05260 | BRD-K09059649 | BRD-K09059649 | -- | -- | -- | Details |
| C05261 | BRD-K09059658 | BRD-K09059658 | -- | -- | -- | Details |
| C05262 | BRD-K09064372 | SA-1919918 | -- | -- | -- | Details |
| C05263 | BRD-K09068728 | BRD-K09068728 | -- | -- | -- | Details |
| C05264 | BRD-K09069264 | BRD-K09069264 | -- | -- | -- | Details |
| C05265 | BRD-K09071517 | BRD-K09071517 | -- | -- | -- | Details |
| C05266 | BRD-K09074846 | BRD-K09074846 | -- | -- | -- | Details |
| C05267 | BRD-K09076022 | BRD-K09076022 | -- | -- | -- | Details |
| C05268 | BRD-K09078201 | BRD-K09078201 | -- | -- | -- | Details |
| C05269 | BRD-K09078998 | deforolimus | MTOR | MTOR inhibitor | -- | Details |
| C05270 | BRD-K09080977 | BRD-K09080977 | -- | -- | -- | Details |
| C05271 | BRD-K09085062 | BRD-K09085062 | -- | -- | -- | Details |
| C05272 | BRD-K09085930 | TUL_XX087 | -- | -- | TUL-XX087 | Details |
| C05273 | BRD-K09090949 | CP-945598 | -- | -- | -- | Details |
| C05274 | BRD-K09100418 | BRD-K09100418 | -- | -- | -- | Details |
| C05275 | BRD-K09106444 | BRD-K09106444 | -- | -- | -- | Details |
| C05276 | BRD-K09108485 | BRD-K09108485 | -- | -- | -- | Details |
| C05277 | BRD-K09110452 | BRD-K09110452 | -- | -- | -- | Details |
| C05278 | BRD-K09112411 | BRD-K09112411 | -- | -- | -- | Details |
| C05279 | BRD-K09117810 | BRD-K09117810 | -- | -- | -- | Details |
| C05280 | BRD-K09124072 | BRD-K09124072 | -- | -- | -- | Details |
| C05281 | BRD-K09129322 | BRD-K09129322 | -- | -- | dehydrocholic-acid | Details |
| C05282 | BRD-K09130601 | BRD-K09130601 | -- | -- | -- | Details |
| C05283 | BRD-K09131889 | BRD-K09131889 | -- | -- | -- | Details |
| C05284 | BRD-K09132007 | D-4476 | CSNK1A1; TGFB1 | TGF beta receptor inhibitor | -- | Details |
| C05285 | BRD-K09137343 | BRD-K09137343 | -- | -- | -- | Details |
| C05286 | BRD-K09138889 | KU-C104131 | -- | -- | -- | Details |
| C05287 | BRD-K09144377 | BRD-K09144377 | -- | -- | -- | Details |
| C05288 | BRD-K09146396 | BRD-K09146396 | -- | -- | -- | Details |
| C05289 | BRD-K09149805 | BRD-K09149805 | -- | -- | -- | Details |
| C05290 | BRD-K09160804 | BRD-K09160804 | -- | -- | -- | Details |
| C05291 | BRD-K09166899 | BRD-K09166899 | -- | -- | -- | Details |
| C05292 | BRD-K09167509 | BRD-K09167509 | -- | -- | -- | Details |
| C05293 | BRD-K09168812 | BRD-K09168812 | -- | -- | -- | Details |
| C05294 | BRD-K09170549 | BRD-K09170549 | -- | -- | -- | Details |
| C05295 | BRD-K09186736 | BRD-K09186736 | -- | -- | -- | Details |
| C05296 | BRD-K09186807 | KIN001-244 | PDPK1 | Phosphoinositide dependent kinase inhibitor | KIN-001-244 | Details |
| C05297 | BRD-K09191014 | BRD-K09191014 | -- | -- | -- | Details |
| C05298 | BRD-K09191212 | BRD-K09191212 | -- | -- | -- | Details |
| C05299 | BRD-K09203309 | BRD-K09203309 | -- | -- | -- | Details |
| C05300 | BRD-K09203354 | BRD-K09203354 | -- | -- | -- | Details |
| C05301 | BRD-K09206831 | BRD-K09206831 | -- | -- | -- | Details |
| C05302 | BRD-K09208538 | BRD-K09208538 | -- | -- | -- | Details |
| C05303 | BRD-K09227140 | BRD-K09227140 | -- | -- | -- | Details |